Albuterol+Budesonide bulk supplier for pharma manufacturers

Albuterol+Budesonide 90mcg+80mcg Suppliers & Bulk Manufacturers

Available Forms: Inhalation

Available Strengths: 90mcg+80mcg

Reference Brands: Airsupra (USA)

Albuterol/Budesonide is a combination inhaler used to manage and prevent asthma and other chronic respiratory conditions. Albuterol is a short-acting β₂-agonist (SABA) that provides quick relief from bronchospasm by relaxing the airway muscles, while Budesonide is an inhaled corticosteroid (ICS) that reduces airway inflammation and prevents asthma attacks. This combination can be used as-needed for immediate relief (in products like Airsupra) or as maintenance therapy (in products like Symbicort or DuoResp) depending on the formulation. It helps improve breathing, reduce wheezing, and lower the frequency of asthma exacerbations.

Ask About Access

Quick Response Guaranteed | Verified Suppliers

Product Description:

This fixed combination of albuterol with budesonide represents a genuine change in asthma treatment strategy rather than a convenience formulation. Conventional practice pairs a short-acting beta-2 agonist used as needed for symptoms with a separately dosed inhaled corticosteroid taken regularly. The difficulty is that patients reliably take the reliever, which produces immediate relief, and unreliably take the controller, which does not.

Combining the two in a single rescue inhaler means every time a patient treats symptoms they also receive an anti-inflammatory dose — an "anti-inflammatory reliever" approach. It is indicated to reduce the risk of exacerbations in asthma.

Sourcing notes. This is a recent, on-patent innovator product. It is not generically available and cannot be quoted as a generic; enquiries seeking bulk supply are, in practice, enquiries for the branded product through authorised distribution. Where the underlying requirement is inhaled corticosteroid plus reliever therapy, the established option is separate albuterol and budesonide inhalers, both widely genericised and readily sourced, or a conventional ICS/LABA combination. That is usually the workable answer to this enquiry. Manufacture in any case requires pressurised metered-dose inhaler capability with combination-product dose uniformity validation, which is held by a small number of sites globally.

How Albuterol+Budesonide is actually supplied

Albuterol+Budesonide is a patented innovator medicine. There is no approved generic or biosimilar, which means it cannot be offered on a wholesale, bulk or third party manufacturing basis by us or by anyone else. Any party offering a generic version is offering something that does not lawfully exist, and that is worth treating as a warning rather than an opportunity.

Named-patient import Where a patient needs the product in a market where it is not registered, named-patient import is the lawful route. It requires the treating physician's documentation and authorisation from the destination regulator. We handle this pathway. Named-patient access

Authorised distribution For registered markets, supply runs through the manufacturer's authorised distribution channel. We can identify the authorised route for your market and tell you whether the product is registered there at all. Innovator sourcing

A genericised alternative Where the clinical requirement is the drug class rather than this specific molecule, there is often an off-patent alternative that is faster to register and materially cheaper. Tell us the indication and target market and we will say plainly whether one exists. Discuss alternatives

Ask about Albuterol+Budesonide supply →

Back to Listing

Frequently Asked Questions

Albuterol+Budesonide is listed as Inhalation in 90mcg+80mcg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Albuterol+Budesonide is referenced against Airsupra (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.